Boston Scientific buy UBS Group AG
Start price
24.07.25
/
50%
€90.40
Target price
24.07.26
€114.66
Performance (%)
-40.60%
Price
13.04.26
€53.70
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Boston Scientific is performing very badly with a performance of -40.60%. This prediction currently runs until 24.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Boston Scientific | -1.648% | -1.648% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by UBS_Group_AG for this prediction
In the thread Boston Scientific diskutieren
Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $130.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Boston Scientific
Boston Scientific
Start price
Target price
Perf. (%)
€62.20
17.03.26
17.03.26
€91.33
17.03.27
17.03.27
-13.67%
13.04.26
13.04.26
Boston Scientific
Start price
Target price
Perf. (%)
€102.00
07.02.25
07.02.25
€125.53
07.02.26
07.02.26
-38.24%
08.02.26
08.02.26
Boston Scientific
Start price
Target price
Perf. (%)
€68.50
25.04.24
25.04.24
€83.95
25.04.25
25.04.25
30.51%
26.04.25
26.04.25